Literature DB >> 9473477

A novel mitochondrial DNA point mutation in the tRNA(Ile) gene: studies in a patient presenting with chronic progressive external ophthalmoplegia and multiple sclerosis.

R W Taylor1, P F Chinnery, M J Bates, M J Jackson, M A Johnson, R M Andrews, D M Turnbull.   

Abstract

We report a new mutation, a G to A transition at nucleotide position 4298 within the mitochondrial tRNA(Ile) gene in a patient with chronic progressive external ophthalmoplegia and multiple sclerosis. The mutation, which alters an evolutionary conserved nucleotide within the anticodon stem, was heteroplasmic in skeletal muscle but was not present in the patient's blood. Single fibre PCR analysis revealed significantly higher levels of the G4298A mutation in cytochrome c oxidase (COX) negative fibres than in COX-positive fibres. This mutation represents the seventh pathogenic nucleotide substitution to be found in this gene and as such confirms the tRNA(Ile) gene as a susceptible "hot spot" for mitochondrial DNA point mutations. Of particular interest is that this patient has the clinical features of both multiple sclerosis and a mitochondrial DNA disorder.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473477     DOI: 10.1006/bbrc.1997.8055

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Mitochondrial DNA analysis: polymorphisms and pathogenicity.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-07       Impact factor: 6.318

Review 2.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

3.  Mitochondrial DNA haplogroups and mutations in children with acquired central demyelination.

Authors:  S Venkateswaran; K Zheng; M Sacchetti; D Gagne; D L Arnold; A D Sadovnick; S W Scherer; B Banwell; A Bar-Or; D K Simon
Journal:  Neurology       Date:  2011-02-02       Impact factor: 9.910

4.  A novel mutation in the tRNAIle gene (MTTI) affecting the variable loop in a patient with chronic progressive external ophthalmoplegia (CPEO).

Authors:  Andres Berardo; Jorida Coku; Bulent Kurt; Salvatore DiMauro; Michio Hirano
Journal:  Neuromuscul Disord       Date:  2010-02-10       Impact factor: 4.296

5.  Impairment of mitochondrial tRNAIle processing by a novel mutation associated with chronic progressive external ophthalmoplegia.

Authors:  A Schaller; R Desetty; D Hahn; C B Jackson; J-M Nuoffer; S Gallati; L Levinger
Journal:  Mitochondrion       Date:  2011-02-01       Impact factor: 4.160

6.  Recurrent myoglobinuria in a sporadic patient with a novel mitochondrial DNA tRNA(Ile) mutation.

Authors:  Valentina Emmanuele; Evangelia Sotiriou; Maryam Shirazi; Kurenai Tanji; Ronald G Haller; Katja Heinicke; Peter E Bosch; Michio Hirano; Salvatore DiMauro
Journal:  J Neurol Sci       Date:  2011-02-15       Impact factor: 3.181

7.  A novel mitochondrial tRNA(Val) T1658C mutation identified in a CPEO family.

Authors:  Naihong Yan; Shuping Cai; Bo Guo; Yi Mou; Jing Zhu; Jun Chen; Ting Zhang; Ronghua Li; Xuyang Liu
Journal:  Mol Vis       Date:  2010-08-25       Impact factor: 2.367

8.  Mitochondrial DNA abnormalities in ophthalmological disease.

Authors:  Grainne S Gorman; Robert W Taylor
Journal:  Saudi J Ophthalmol       Date:  2011-02-18

9.  Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO.

Authors:  Laura C Greaves; Patrick Yu-Wai-Man; Emma L Blakely; Kim J Krishnan; Nina E Beadle; Jamie Kerin; Martin J Barron; Philip G Griffiths; Alison J Dickinson; Douglass M Turnbull; Robert W Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

10.  Evolution meets disease: penetrance and functional epistasis of mitochondrial tRNA mutations.

Authors:  Raquel Moreno-Loshuertos; Gustavo Ferrín; Rebeca Acín-Pérez; M Esther Gallardo; Carlo Viscomi; Acisclo Pérez-Martos; Massimo Zeviani; Patricio Fernández-Silva; José Antonio Enríquez
Journal:  PLoS Genet       Date:  2011-04-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.